Basaglar (insulin glargine)

pCPA File Number: 20930
Negotiation Status:
Concluded with an LOI
Indication(s):
Diabetes Mellitus, Type 1 & 2
Sponsor/Manufacturer:
Eli Lilly Canada Inc.
CDA-AMC Project Number:
SE0451-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: